The FOXP3-exon 2-related suppressive activity of Tregs was impaired in human autoimmune diseases, including multiple sclerosis and type 1 diabetes, and was associated with impaired glycolysis and signaling via IL-2 (16). Here, FOXP3 is linked to autoimmune disease.